A study conducted by scientists from Inserm, CNRS, Lille University Hospital, University of Lille, and the Pasteur Institute of Lille, published in the journal "Diabetes," reveals how diabetes
Type 2 can cause epigenetic changes leading to pancreatic cancer. Led by the Dr. Amna Khamis and Professor Froguel From the University of Lille, this research offers
new perspectives for the prevention and treatment of one of the most aggressive cancers.
Patients with type 2 diabetes have a higher risk of developing pancreatic cancer than those without the condition. This is one of the deadliest cancers because it is
It is usually diagnosed too late. It is crucial to know the early events related to diabetes that promote the development of this cancer in order to better prevent and fight it.
Find out more
